Drug use in off-label dosage regimes

Drug use in off-label dosage regimes

Saved in:

Bibliographic Details
Main Author:	Roberto Lozano Ortiz
Format:	Article
Language:	English
Published:	Elsevier 2015-01-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/8471.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Off-Label Drug Use in Oncology
by: E. V. Karabina, et al.
Published: (2022-07-01)

Off-label use of psychotropic drugs in youth
by: Haakon Gravanti Rosland, et al.
Published: (2025-07-01)

Automated detection of off-label drug use.
by: Kenneth Jung, et al.
Published: (2014-01-01)

The peculiarities of off-label use of drugs in pediatrics
by: S. M. Drohovoz, et al.
Published: (2020-10-01)

Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01)

Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01)

Off-label Use of Devices and Drugs in Interventional Radiology
by: Shikhar Garg, et al.
Published: (2023-12-01)

Off-Label Drug Use in Pediatric Practice: Unsolved Problems
by: A. R. Titova, et al.
Published: (2015-10-01)

Current issues related to the off-label use of drugs and their potential solutions
by: K. S. Radaeva, et al.
Published: (2024-04-01)

EXTENT OF UNLICENSED AND OFF-LABEL DRUG USE IN THE PEDIATRIC PRACTICE OF SMOLENSK
by: S.A. Rachina, et al.
Published: (2010-07-01)

Exploration of Ethical Review Disputes and Regulatory Pathways of Off-label Drug Use
by: Xuelian TANG, et al.
Published: (2025-02-01)

Legal Responsibility of Doctor Regarding off-label Drug Applications
by: Erdal Yüzbaşıoğlu
Published: (2012-03-01)

Off-label drug use in China after the Physician Law (2021): legal challenges and solutions
by: Shenbao Liang, et al.
Published: (2025-04-01)

Use of Off-Label Drugs and Nutrition Supplements among Patients with Amyotrophic Lateral Sclerosis in Norway
by: Gard Aasmund Skulstad Johanson, et al.
Published: (2022-01-01)

Off-label use of atomoxetine in adults: is it safe?
by: Peter Silverstone, et al.
Published: (2012-07-01)

“Off-label” drugs: legal problems and socio-economic aspects of application practice
by: S. V. Russkikh, et al.
Published: (2023-08-01)

ON THE SELECTION OF DRUGS DOSAGE REGIMEN
by: E. N. Bochanova
Published: (2015-09-01)

Calculation of drug dosages : a work text /
by: Ogden, Sheila J., 1949-
Published: (2012)

Safety of the Off-Label Use of Antitumor Drugs in Real Clinical Practice: Experience of Oncologists of the Russian Federation
by: E. V. Каrabina, et al.
Published: (2024-12-01)

Off-label drug use in pediatric patients: a comparative analysis with nationwide routine prescription data
by: Narin Akıcı, et al.
Published: (2020-12-01)

Off-label dermatologic uses of IL-23 inhibitors
by: Justin Porter, et al.
Published: (2024-12-01)

Experience of off-label use of Eltrombopag in the treatment of thrombocytopenia associated with solid tumors
by: María Henar García Lagunar, et al.
Published: (2015-02-01)

List of diseases with off-label treatment
by: article Editorial
Published: (2022-05-01)

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center’s real-world approach
by: E. Cioli, et al.
Published: (2025-03-01)

Prevalence and relationship with health of off-label and contraindicated drug use in the United States: a cross-sectional study
by: Katharina E. Blankart, et al.
Published: (2025-12-01)

Analysis of off-label drug use and its influencing factors in pediatric patients undergoing otolaryngology, head, and neck surgery
by: Zichao Ji, et al.
Published: (2025-05-01)

Off-Label Medicines Use: Complex Problem of Modern Clinical Practice
by: S. R. Gilyarevskiy
Published: (2020-05-01)

Legal and Medical Aspects of Off-Label Medication Use. Point of View
by: O. V. Tsygankova, et al.
Published: (2019-03-01)

The prevalence and consequences of support for off-label Ozempic prescriptions
by: Timothy Callaghan, et al.

Ophthalmic Drug Dosage Forms: Characterisation and Research Methods
by: Przemysław Baranowski, et al.
Published: (2014-01-01)

Effect of oral antihypertensive drugs on biochemical dosages in the elderly
by: Maria Elizana Martins de Meneses Carvalho, et al.
Published: (2016-12-01)

Effect of oral antihypertensive drugs on biochemical dosages in the elderly
by: Maria Elizana Martins de Meneses Carvalho, et al.
Published: (2016-12-01)

Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review
by: Vítor Silva, et al.
Published: (2024-11-01)

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
by: O. V. Tsygankova, et al.
Published: (2019-12-01)

Bridging the Gap: A Systematic Review with Expert Opinion on the Use of Dalbavancin for In-Label and Off-Label Indications in Pediatric Patients
by: Désirée Caselli, et al.
Published: (2025-01-01)

Off-Label Use of Monoclonal Antibodies for Eosinophilic Esophagitis in Humans: A Scoping Review
by: Benyu Yang, et al.
Published: (2024-11-01)

Assessment of mandatory declaration excipients in pediatric off label prescriptions in Spain
by: Irene Lizano-Díez, et al.
Published: (2025-07-01)

Clinical, microbiological, and laboratory predictors of on- and off-label dalbavancin treatment failure
by: Maria Mazzitelli, et al.
Published: (2025-06-01)

Modifying drug dosages in oncology: immense need for innovative oncology treatments
by: Karamitrousis Evangelos, et al.
Published: (2024-11-01)

Use of cannabidiol for off-label treatment of patients with refractory focal, genetic generalised and other epilepsies
by: Marie Hollander, et al.
Published: (2025-07-01)